These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9453617)

  • 1. Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin.
    Ballard JD; Doling AM; Beauregard K; Collier RJ; Starnbach MN
    Infect Immun; 1998 Feb; 66(2):615-9. PubMed ID: 9453617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein.
    Zhang Y; Kida Y; Kuwano K; Misumi Y; Ikehara Y; Arai S
    Microbiol Immunol; 2001; 45(2):119-25. PubMed ID: 11293477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo.
    Ballard JD; Collier RJ; Starnbach MN
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12531-4. PubMed ID: 8901616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin as a molecular tool for stimulation of cytotoxic T lymphocytes: disulfide-linked epitopes, multiple injections, and role of CD4(+) cells.
    Ballard JD; Collier RJ; Starnbach MN
    Infect Immun; 1998 Oct; 66(10):4696-9. PubMed ID: 9746566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.
    Doling AM; Ballard JD; Shen H; Krishna KM; Ahmed R; Collier RJ; Starnbach MN
    Infect Immun; 1999 Jul; 67(7):3290-6. PubMed ID: 10377103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
    J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen.
    Kushner N; Zhang D; Touzjian N; Essex M; Lieberman J; Lu Y
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6652-7. PubMed ID: 12740437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R
    Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin.
    Shaw CA; Starnbach MN
    Infect Immun; 2008 Jun; 76(6):2603-11. PubMed ID: 18347032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.
    Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T
    Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
    Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y; Li Y; Kapp JA
    Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes.
    Takemoto S; Nishikawa M; Guan X; Ohno Y; Yata T; Takakura Y
    Mol Pharm; 2010 Oct; 7(5):1715-23. PubMed ID: 20695521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.
    Schirmbeck R; Böhm W; Reimann J
    Eur J Immunol; 1994 Sep; 24(9):2068-72. PubMed ID: 8088327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
    Carbone FR; Bevan MJ
    J Exp Med; 1989 Mar; 169(3):603-12. PubMed ID: 2784478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.